Metacrine, Inc. Profile Avatar - Palmy Investing

Metacrine, Inc.

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative …

Biotechnology
US, San Diego [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Metacrine, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Metacrine, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Metacrine, Inc..

End of MTCR's Analysis
CIK: 1634379 CUSIP: 59101E103 ISIN: US59101E1038 LEI: - UEI: -
Secondary Listings
MTCR has no secondary listings inside our databases.